Health Care: Drugs

Illumina Inc (ILMN: NASDAQ)

$121.414 -4.986 | -3.94%
12/07/16 - 12:56 PM ET
Company Profile
Price and Volume
Recent Price 126.40
52 Week High 196.47
52 Week Low 125.10
Avg. Daily Vol. (Mil) 1.49
Beta (3 year) 0.76
Share Related Items
Mkt Cap (Mil) 18,568.16
Shares Out (Mil) 146.90
Float (Mil) 128.11
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.00
Current Ratio 3.60
LT Debt/ Equity 0.46
Total Debt / Equity 0.47
Valuation Ratios
Price Earnings 42.10
Price/Sales 7.83
Price/Book 8.29
Price/Cash Flow 31.40
Per Share Data
Earnings 3.00
Sales 16.14
Book Value 15.25
Cash Flow 4.02
Business Summary
Illumina Inc provides sequencing-and array-based solutions for genetic analysis. Its products enabled researchers to explore DNA, helping them create the first map of gene variations associated with health, disease, and drug response.
General Information
5200 Illumina Way
San Diego, CA 92122
www.illumina.com
Industry : Drugs
Sector: Health Care
Employees: 4600
CEO: Francis A. DeSouza
Short Interest
Current Month (Mil) 4.40
Previous Month (Mil) 5.26
Short Interest Ratio (Days) 2.80
Management Effectiveness
Return on Equity 18.90
Return on Assets 10.00
Return on Investments 12.90
Profitability
Gross Margin 77.00
EBIT Margin 25.00
Profit Margin 17.90

Portfolios with ILMN

Latest ILMN Headlines from TheStreet

More Financial News for ILMN

Press Releases for ILMN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter